醫藥相關股發力 微創機械人、信達生物、金斯瑞、康方、藥明生物及啟明醫療急彈6%-17%
港股四連升,恆指今天在新經濟股、保險股及港交所(00388.HK)受捧帶動,最多升逾500點高見19,368,現報19,341,續升480點或2.5%,總成交額增至1,019億元。
醫藥及醫療股今天普遍升逾2%。啟明醫療-B(02500.HK)重越20天及10天線,最多急漲23%高見7.43元,現報7.06元,急彈17%,成交急增至1,345萬股。微創機械人-B(02252.HK)重越20天線,最多彈6.8%至21.9元,現報21.75元,回升6.1%。
康希諾生物(06185.HK)、騰盛博藥-B(02137.HK)、藥明康德(02359.HK)及君實生物(01877.HK)升逾半成;信達生物(01801.HK)、金斯瑞(01548.HK)、康方生物(09926.HK)及藍籌藥明生物(02269.HK)漲逾6%-9%,後者彈力最強,股價重越10天及20天線,最高見41.45元。
諾誠健華-B(09969.HK)重越50天線,最高見7.92元,現報7.85元,續升4.5%。持續受惠盈喜的3D MEDICINES-B(01244.HK)六連升兼屢創上市新高,今天反覆高見131.5元,現報125元,續升2.3%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.